ClinicalTrials.Veeva

Menu

Efficacy Study of Shortwave Diathermy for the Treatment of Patients With Knee Osteoarthritis

M

Mahidol University

Status and phase

Completed
Phase 3

Conditions

Menopause
Osteoarthritis, Knee

Treatments

Device: Shortwave diathermy

Study type

Interventional

Funder types

Other

Identifiers

NCT00199914
34/2003

Details and patient eligibility

About

The purpose of this study is to determine whether shortwave diathermy is effective in reducing knee pain and increasing function of the patients with knee osteoarthritis.

Full description

Osteoarthritis (OA) is the most common degenerative joint disease, resulting in significant morbidity and health care expense. It affects more than 60% of Western World adults over the age of 65 years. It causes pain and dysfunction in 20% of elderly persons. It can affect any joint containing hyaline cartilage; knee is the most commonly affected joint. There are many strategies for the treatment of knee OA but a curative method has not been found. Treatment is therefore aimed to relief symptoms and to prevent further functional deterioration. It is unclear whether any of the treatment modalities is efficacious. Shortwave diathermy (SWD) is one of deep heat widely applied to alleviate the symptoms associated with OA. The efficacy of SWD for the treatment of OA knee is still inconclusive. The outcome of treatment in previous reports varies from null to positive effect. This discrepancy is largely due to the different research methodology, the inadequate sample size, the methods used in outcome assessment, and the treatment protocols.

Comparison(s): Peri- or postmenopausal women with OA knee are randomized into two groups, receiving a course of either therapeutic SWD or sham SWD. The main outcome measured is the change in Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index.

Enrollment

113 patients

Sex

Female

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • peri- or postmenopausal women aged >50 years
  • primary knee osteoarthritis

Exclusion criteria

  • inability to walk
  • severe joint instability
  • history of previous shortwave diathermy
  • intra-articular injection within 3 months
  • metallic implant around knee joint
  • suspicious of malignancy around knee joint
  • significant cardiovascular disease
  • inability to understand how to score the symptoms

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

113 participants in 2 patient groups

Shortwave diathermy
Experimental group
Description:
continuous shortwave diathermy, 20 min/session, 3 sessions/week for 3 weeks
Treatment:
Device: Shortwave diathermy
control
Sham Comparator group
Description:
continuous sham shortwave diathermy, 20 min/session, 3 sessions/week for 3 weeks
Treatment:
Device: Shortwave diathermy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems